McKesson extends CVS deal. McKesson stock yields 0.37 percent
Published on 10/06/2026 at 17:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
McKesson (ISIN US58155Q1031) was last at EUR 819.80 at Lang & Schwarz on October 5, 2026, and its stock carried a 0.37 percent dividend yield. On October 1, 2026, Business Wire reported that McKesson signed an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032.
CVS agreement extends through 2032
The agreement covers mail-order and specialty pharmacies, retail pharmacies, and distribution centers. Its status remains an agreement in principle, so the release identifies execution risk through possible delays in signing the definitive contract and in realizing expected operational benefits.
McKesson also reaffirmed fiscal 2027 adjusted earnings-per-share guidance of USD 44.20 to USD 45.00 and long-term adjusted earnings-per-share growth of 13 percent to 16 percent, according to Business Wire on October 1, 2026. The company plans to provide further updates with its fiscal 2027 second-quarter results on November 4, 2026.
First-quarter growth supports guidance
For the first quarter of fiscal 2027, McKesson reported revenue of USD 105.38 billion, up 7.70 percent year over year, while adjusted earnings per share reached USD 9.93 versus USD 8.26 in the prior-year quarter. MarketBeat reported that adjusted earnings per share exceeded the USD 9.56 consensus estimate by USD 0.37, while revenue exceeded the USD 103.88 billion estimate.
The comparison matters because McKesson operates on a narrow distribution margin, making volume, specialty-drug activity, and earnings growth more informative than revenue alone. The latest quarter paired higher revenue with a 20.22 percent increase in adjusted earnings per share, while the reaffirmed guidance range keeps the next earnings report as the clearest test of the CVS agreement's financial relevance.
McKesson stock stays above prior close
McKesson stock was last at EUR 819.80 at Lang & Schwarz on October 5, 2026 at 9:38 p.m. CEST, up 2.45 percent versus the Lang & Schwarz close of EUR 800.20 on October 2, 2026. The primary listing is on the NYSE, where finance data showed an intraday price of USD 917.23 at 11:07 a.m. ET on October 6, 2026, with a market capitalization of USD 107.4 billion.
McKesson stock facts
- Company: McKesson Corporation
- ISIN: US58155Q1031
- Ticker: MCK
- Primary exchange: NYSE
- Price substitute Lang & Schwarz as of October 5, 2026, 9:38 p.m. CEST: EUR 819.80
- Change versus Lang & Schwarz close: plus 2.45 percent
- Lang & Schwarz close October 2, 2026: EUR 800.20
- Market capitalization: USD 107.4 billion as of October 6, 2026
- Sector / Industry: Healthcare / Medical Distribution
- Index membership: S&P 500
